AstraZeneca will launch a new online platform to make Airsupra, as well as Farxiga and Flumist, available for home delivery ...
Recent analysis reveals Medicaid's impact on mortality, highlighting the need for diverse research methods to inform policy ...
Tavapadon is an investigational, novel, once-daily treatment option for Parkinson’s disease, which currently affects more ...
A new targeted therapy has shown promise for a difficult-to-treat subset of lung cancer. In a multinational phase 2 trial, the oral drug sunvozertinib produced durable tumor responses in patients with ...
The expiration of ACA tax credits threatens $32 billion in healthcare revenue, risking coverage for millions and increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback